Pharmaceutical Pricing Lacks Transparency – Science 2.0

Pharmaceutical Pricing Lacks Transparency
Science 2.0
Writing in the Journal of the Royal Society of Medicine, the authors of an essay on market-access agreements for anti-cancer drugs say agreements on prices are an opportunistic way for pharmaceutical manufacturers to keep official prices high. There
Pricing for new drugs lacks transparencyMedical Xpress
Quick access to new drug schemes lack transparencyOnMedica

all 4 news articles >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd